Encompass Design India logo

Encompass Design India MD, chairman, board of directors and AGM

NSE: ENCOMPASCommercial Services & Supplies

Last close ₹238.80up ₹10.05 (4.39%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹228.75.

Range of traded prices from listing on 12 Dec 2025 to 23 Oct 2026
₹167.35Low, 17 Dec 2025₹302.90High, 13 Apr 2026
Market cap
₹339 Cr
P/E
26.0
P/B
4.1
Dividend yield
Nonesince listing in Dec 2025
ROE
15.9%
Debt to equity
0.16
Volume, NSE
48,80099.2% delivered

Encompass Design India board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

    An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

    Statutory auditor

    Named in the results for the quarter to Mar 2026.

    • M/s V K BeswalPeer-review certificate valid to Jul 2027

    A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

    Encompass Design India AGM and shareholder votes

    Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Encompass Design India share news and announcements

    Annual general meeting, 30 Sep 2026

    324 shareholders on the register on 23 Sep 2026; present: 3 promoters and 12 others; votes counted by Shanu Bhagwandas Mata / Shanu Mata and Associates.The company's voting result (opens in a new tab)

    1. To receive consider and adopt the audited financial statements of the Company for the financial year ended 31st March, 2026 and the reports of the Board of Directors and Auditors thereon.
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 64.82% · promoters 100.00% · institutions 0.00% · other public 18.78%

    2. To appoint a Director in place of Mrs. Susmita Amit Dalmia (DIN: 02401290), who retires by rotation and being eligible, offers herself for re-appointment:
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 64.82% · promoters 100.00% · institutions 0.00% · other public 18.78%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Extraordinary general meeting, 17 Aug 2026, 1 resolution

    341 shareholders on the register on 10 Aug 2026; present: 4 promoters and 10 others; votes counted by Shanu Bhagwandas Mata / Shanu Mata and Associates.The company's voting result (opens in a new tab)

    1. To approve the issuance of equity shares by way of preferential issue
      SpecialPromoters have an interest in it
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 66.30% · promoters 100.00% · institutions 34.26% · other public 13.61%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Investor complaints and compliance

    Quarter by quarter.

    Investor complaints received and resolved, the company's own count

    • Received
    • Resolved

    Open at the quarter's end

    None open at any quarter's end.
    The filing has a part on fines and penalties
    No
    The filing has a part on tax disputes
    No

    The company's own answers in its filing.

    How money raised was used

    Reported for the quarter to Mar 2026. Where a statement's revised amounts repeat the whole raise, the amounts first set aside are shown instead.

    RaisedAmount raisedForSet asideSpentSpent elsewhereSpent elsewhere, amountReason and comments
    Public IssuesDec 2025, checked by CARE Ratings Limited40.21Funding capital expenditure requirements of our company towards purchasing office, interior work and refurbishment114.86112.03Yes
    Pursuant to shareholders’ approval dated March 30, 2026, the Company reallocated ₹1.16 crore out of the unutilised IPO proceeds originally earmarked towards repayment/prepayment of borrowings and issue-related expenses to meet working capital requirements, as the original objectives had been substantially achieved.MoreLess
    Audit committee: The Audit Committee has reviewed the variation in utilisation of IPO proceeds and noted that the reallocation is in line with the shareholders’ approval and is in the best interest of the Company considering the operational and working capital requirements.MoreLess
    Auditors: Subsequent to the reporting date, the shareholders of the Company at the Extraordinary General Meeting held on March 30, 2026 approved variation in utilisation of IPO proceeds in accordance with the Companies Act, 2013 and SEBI regulations. Out of the unutilised IPO proceeds of ₹5.05 crore, ₹1.16 crore originally earmarked towards repayment/prepayment of borrowings and issue-related expenses was reallocatedMoreLess
    Public IssuesDec 2025, checked by CARE Ratings Limited40.21To meet working capital requirements of the company7.293.75Yes1.16
    Pursuant to shareholders’ approval dated March 30, 2026, the Company reallocated ₹1.16 crore out of the unutilised IPO proceeds originally earmarked towards repayment/prepayment of borrowings and issue-related expenses to meet working capital requirements, as the original objectives had been substantially achieved.MoreLess
    Audit committee: The Audit Committee has reviewed the variation in utilisation of IPO proceeds and noted that the reallocation is in line with the shareholders’ approval and is in the best interest of the Company considering the operational and working capital requirements.MoreLess
    Auditors: Subsequent to the reporting date, the shareholders of the Company at the Extraordinary General Meeting held on March 30, 2026 approved variation in utilisation of IPO proceeds in accordance with the Companies Act, 2013 and SEBI regulations. Out of the unutilised IPO proceeds of ₹5.05 crore, ₹1.16 crore originally earmarked towards repayment/prepayment of borrowings and issue-related expenses was reallocatedMoreLess
    Public IssuesDec 2025, checked by CARE Ratings Limited40.21Repayment/ prepayment of certain borrowings availed by our company11.0010.72Yes
    Pursuant to shareholders’ approval dated March 30, 2026, the Company reallocated ₹1.16 crore out of the unutilised IPO proceeds originally earmarked towards repayment/prepayment of borrowings and issue-related expenses to meet working capital requirements, as the original objectives had been substantially achieved.MoreLess
    Audit committee: The Audit Committee has reviewed the variation in utilisation of IPO proceeds and noted that the reallocation is in line with the shareholders’ approval and is in the best interest of the Company considering the operational and working capital requirements.MoreLess
    Auditors: Subsequent to the reporting date, the shareholders of the Company at the Extraordinary General Meeting held on March 30, 2026 approved variation in utilisation of IPO proceeds in accordance with the Companies Act, 2013 and SEBI regulations. Out of the unutilised IPO proceeds of ₹5.05 crore, ₹1.16 crore originally earmarked towards repayment/prepayment of borrowings and issue-related expenses was reallocatedMoreLess
    Public IssuesDec 2025, checked by CARE Ratings Limited40.21General corporate purpose5.595.59Yes
    Pursuant to shareholders’ approval dated March 30, 2026, the Company reallocated ₹1.16 crore out of the unutilised IPO proceeds originally earmarked towards repayment/prepayment of borrowings and issue-related expenses to meet working capital requirements, as the original objectives had been substantially achieved.MoreLess
    Audit committee: The Audit Committee has reviewed the variation in utilisation of IPO proceeds and noted that the reallocation is in line with the shareholders’ approval and is in the best interest of the Company considering the operational and working capital requirements.MoreLess
    Auditors: Subsequent to the reporting date, the shareholders of the Company at the Extraordinary General Meeting held on March 30, 2026 approved variation in utilisation of IPO proceeds in accordance with the Companies Act, 2013 and SEBI regulations. Out of the unutilised IPO proceeds of ₹5.05 crore, ₹1.16 crore originally earmarked towards repayment/prepayment of borrowings and issue-related expenses was reallocatedMoreLess
    Public IssuesDec 2025, checked by CARE Ratings Limited40.21Issue Proceeds4.8539.65Yes
    Pursuant to shareholders’ approval dated March 30, 2026, the Company reallocated ₹1.16 crore out of the unutilised IPO proceeds originally earmarked towards repayment/prepayment of borrowings and issue-related expenses to meet working capital requirements, as the original objectives had been substantially achieved.MoreLess
    Audit committee: The Audit Committee has reviewed the variation in utilisation of IPO proceeds and noted that the reallocation is in line with the shareholders’ approval and is in the best interest of the Company considering the operational and working capital requirements.MoreLess
    Auditors: Subsequent to the reporting date, the shareholders of the Company at the Extraordinary General Meeting held on March 30, 2026 approved variation in utilisation of IPO proceeds in accordance with the Companies Act, 2013 and SEBI regulations. Out of the unutilised IPO proceeds of ₹5.05 crore, ₹1.16 crore originally earmarked towards repayment/prepayment of borrowings and issue-related expenses was reallocatedMoreLess
    ₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.